Unknown PHASE4 INTERVENTIONAL 2-arm NCT02241590

Treatment of Liver Cirrhosis Due to Hepatitis B Virus With Fuzheng Huayu and Entecavir

A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Study to Assess the Efficacy and Safety of Fuzheng Huayu Combined With Entecavir in Liver Cirrhosis Patients Due to Hepatitis B Virus

Sponsor: Affiliated Hospital of Shandong Univercity of TCM

Conditions Liver Cirrhosis Due to Hepatitis B Virus

Interventions Entecavir + Fuzheng Huayu Tablet Entecavir + Placebo

Updated 12 times since 2017 Last updated: Oct 12, 2018 Started: Sep 30, 2014 Primary completion: Jun 30, 2019 Completion: Jun 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02241590, this PHASE4 trial focuses on Liver Cirrhosis Due to Hepatitis B Virus and remains ongoing. Sponsored by Affiliated Hospital of Shandong Univercity of TCM, it has been updated 12 times since 2014, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

12 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE4
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Nov 2020 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status

▶ Show 7 earlier versions

Sep 2020 — Nov 2020 [monthly]

Recruiting PHASE4
Dec 2018 — Sep 2020 [monthly]

Recruiting PHASE4
Nov 2018 — Dec 2018 [monthly]

Recruiting PHASE4
Sep 2018 — Nov 2018 [monthly]

Recruiting PHASE4

Status: Unknown Status → Recruiting
Jun 2018 — Sep 2018 [monthly]

Unknown Status PHASE4
Feb 2018 — Jun 2018 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Jan 2017 — Feb 2018 [monthly]

Recruiting PHASE4

First recorded

Sep 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Affiliated Hospital of Shandong Univercity of TCM
Beijing Ditan Hospital
Beijing YouAn Hospital
China-Japan Friendship Hospital
Fifth Hospital of Shijiazhuang City
Guangxi Ruikang Hospital
Huai'an No. 4 People's Hospital
Hubei Hospital of Traditional Chinese Medicine
Jingmen No.1 People's Hospital
Ruijin Hospital
Shanghai Zhongshan Hospital
Shenzhen Third People's Hospital
ShuGuang Hospital
The Fifth People's Hospital of Anyang
The Fifth People's Hospital of Suzhou
The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine
The Ninth Hospital of Nanchang
The People's Hospital of Ningxia
Tongji Hospital
Wenzhou Central Hospital

Data source: ShuGuang Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Anyang, China , Beijing, China , Changsha, China , Huai'an, China , Jinan, China , Jingmen, China , Nanchang, China , Nanning, China , Shanghai, China , Shenzhen, China and 5 more locations